Equities

Infinium Pharmachem Ltd

INFINIUM:NSI

Infinium Pharmachem Ltd

Actions
  • Price (INR)294.10
  • Today's Change22.10 / 8.13%
  • Shares traded75.50k
  • 1 Year change-6.47%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 10:57 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments1196055
Total Receivables, Net261222203
Total Inventory270197164
Prepaid expenses------
Other current assets, total0.013416
Total current assets650513437
Property, plant & equipment, net197188127
Goodwill, net------
Intangibles, net000
Long term investments000
Note receivable - long term--3.111.14
Other long term assets7.74--0.00
Total assets855706590
LIABILITIES
Accounts payable4568118
Accrued expenses------
Notes payable/short-term debt3415689
Current portion long-term debt/capital leases0.8536--
Other current liabilities, total95108107
Total current liabilities174368315
Total long term debt78101136
Total debt112292225
Deferred income tax------
Minority interest15128.19
Other liabilities, total------
Total liabilities267481459
SHAREHOLDERS EQUITY
Common stock1395110
Additional paid-in capital------
Retained earnings (accumulated deficit)449----
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.52)175121
Total equity588226131
Total liabilities & shareholders' equity855706590
Total common shares outstanding141014
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.